Finding 502629 (2023-005)

Material Weakness Repeat Finding
Requirement
I
Questioned Costs
$1
Year
2023
Accepted
2024-10-14
Audit: 324609
Organization: Promise Healthcare Nfp (IL)

AI Summary

  • Core Issue: The Organization failed to verify that a vendor was not suspended or debarred before entering into a contract, leading to potential misuse of federal funds.
  • Impacted Requirements: This finding violates the suspension and debarment regulations outlined in § 200.214 and 2 CFR part 180.
  • Recommended Follow-Up: Implement a process to verify vendor status before contract signing or establish an approved vendor list to ensure compliance.

Finding Text

2023-005 – Suspension and Debarment Federal agency: U.S. Department of Health and Human Services Federal program title: Health Centers Cluster Assistance Listing Number: 93.224/93.527 Pass-Through Agency: n/a Pass-Through Number(s): n/a Award Period: 9/1/23-8/31/25; 4/1/21-3/31/23; 6/1/19-5/31/23; 6/1/23-5/31/26; 12/1/22-5/31/23 Type of Finding: Material Noncompliance and Material Weakness in Internal Control over Compliance Criteria or Specific Requirement: § 200.214 Suspension and debarment. Non-Federal entities are subject to the non-procurement debarment and suspension regulations implementing Executive Orders 12549 and 12689, 2 CFR part 180. The regulations in 2 CFR part 180 restrict awards, subawards, and contracts with certain parties that are debarred, suspended, or otherwise excluded from or ineligible for participation in Federal assistance programs or activities. Condition: The Organization could not provide documentation that vendor was verified as not being suspended or debarred prior to entering into the transaction. Questioned Costs: $48,472. Context: One of one vendor selected for testing suspension and debarment did not have documentation showing that suspension and debarment had been checked prior to entering into a contract. Cause: Management turnover. Effect: The Organization could enter into transactions using federal dollars with vendors that are suspended or debarred. Repeat Finding: Yes, 2022-005. Recommendation: We recommend that the Organization verify that vendors are not suspended or debarred prior to signing contracts or create an approved vendor list. Views of Responsible Officials: There is no disagreement with the audit finding.

Corrective Action Plan

Action taken in response to finding: 1. Create procedure to verify vendors are not suspended or debarred: in progress a. Develop steps in the vendor diligence and procurement process to verify that the vendor is not suspended or debarred. b. Identify role or job that will handle responsibility for following procedure. c. Formalize the process into a written procedure and add to the procurement or other relevant policy. d. Conduct periodic audits to assess adherence to the procedure and train as necessary to ensure compliance. Name of the contact person responsible for corrective action: Keith Flores, CFO Planned completion date for corrective action plan: End of 2024

Categories

Questioned Costs Procurement, Suspension & Debarment

Other Findings in this Audit

  • 502620 2023-002
    Material Weakness
  • 502621 2023-002
    Material Weakness
  • 502622 2023-002
    Material Weakness
  • 502623 2023-002
    Material Weakness
  • 502624 2023-003
    Material Weakness
  • 502625 2023-003
    Material Weakness
  • 502626 2023-003
    Material Weakness
  • 502627 2023-004
    Material Weakness Repeat
  • 502628 2023-004
    Material Weakness Repeat
  • 502630 2023-006
    Significant Deficiency
  • 502631 2023-007
    Significant Deficiency Repeat
  • 502632 2023-007
    Significant Deficiency Repeat
  • 502633 2023-007
    Significant Deficiency Repeat
  • 502634 2023-008
    Significant Deficiency
  • 1079062 2023-002
    Material Weakness
  • 1079063 2023-002
    Material Weakness
  • 1079064 2023-002
    Material Weakness
  • 1079065 2023-002
    Material Weakness
  • 1079066 2023-003
    Material Weakness
  • 1079067 2023-003
    Material Weakness
  • 1079068 2023-003
    Material Weakness
  • 1079069 2023-004
    Material Weakness Repeat
  • 1079070 2023-004
    Material Weakness Repeat
  • 1079071 2023-005
    Material Weakness Repeat
  • 1079072 2023-006
    Significant Deficiency
  • 1079073 2023-007
    Significant Deficiency Repeat
  • 1079074 2023-007
    Significant Deficiency Repeat
  • 1079075 2023-007
    Significant Deficiency Repeat
  • 1079076 2023-008
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.526 Fip Verification $478,998
93.354 Public Health Emergency Response: Cooperative Agreement for Emergency Response: Public Health Crisis Response $220,580
93.268 Immunization Cooperative Agreements $178,382
93.527 Affordable Care Act (aca) Grants for New and Expanded Services Under the Health Center Program $177,552
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $136,658
93.332 Cooperative Agreement to Support Navigators in Federally-Facilitated Exchanges $40,283
93.498 Provider Relief Fund and American Rescue Plan (arp) Rural Distribution $39,862
93.994 Maternal and Child Health Services Block Grant to the States $25,000
93.224 Community Health Centers $14,966
93.322 Cdc Partnership: Strengthening Public Health Laboratories $13,399